| Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. | |
| | |
MedLine Citation:
|
PMID: 21898709 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Prenatal serotonin reuptake inhibitor (SRI) exposure has been related to adverse newborn neurobehavioral outcomes; however, these effects have not been compared to those that may arise from prenatal exposure to maternal major depressive disorder (MDD) without SRI treatment. This study examined potential effects of MDD with and without SRI treatment on newborn neurobehavior. METHODS: This was a prospective, naturalistic study. Women were seen at an outpatient research center twice during pregnancy (26-28 and 36-38 weeks gestational age (GA)). Psychiatric diagnoses were assessed using the Structured Clinical Interview for the DSM-IV; medication use was measured with the Timeline Follow-Back instrument. Three groups were established based upon MDD diagnosis and SRI use: Control (N = 56), MDD (N = 20), or MDD + SRI (N = 36). Infants were assessed on a single occasion within 3 weeks of birth with the NICU Network Neurobehavioral Assessment Scale. Generalized Linear Modeling was used to examine neurobehavioral outcomes by exposure group and infant age at assessment. RESULTS: Full-term infants exposed to MDD + SRIs had a lower GA than CON or MDD-exposed infants and, controlling for GA, had lower quality of movement and more central nervous system stress signs. In contrast, MDD-exposed infants had the highest quality of movement scores while having lower attention scores than CON and MDD + SRI-exposed infants. CONCLUSION: MDD + SRI-exposed infants seem to have a different neurobehavioral profile than MDD-exposed infants in the first 3 weeks after delivery; both groups may have different neurobehavioral profiles with increasing age from birth. |
| | |
Authors:
|
Amy L Salisbury; Katherine L Wisner; Teri Pearlstein; Cynthia L Battle; Laura Stroud; Barry M Lester |
Related Documents
:
|
22123889 - Preterm milk oligosaccharides during the first month of lactation. 21894349 - Survival and long-term neurodevelopmental outcome of the extremely preterm infant. a sy... 21874709 - Formula and scale for body surface area estimation in high-risk infants. 21885049 - New estimates and trends regarding unsafe abortion mortality. 22194469 - Volume-targeted ventilation in infants born at or near term. 21604999 - Maternal and neonatal profile of late-preterm survivors in a poorly resourced country. 15213939 - Massive leiomyosarcoma of the testis in an infant. 4036879 - Discrepant fibrinogen values during thrombolytic therapy. comparison of aca and data-fi... 3242529 - Etiologic heterogeneity of intracranial hemorrhages in preterm newborns. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2011-09-02 |
Journal Detail:
|
Title: Depression and anxiety Volume: 28 ISSN: 1520-6394 ISO Abbreviation: Depress Anxiety Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-14 Completed Date: 2012-04-06 Revised Date: 2013-02-19 |
Medline Journal Info:
|
Nlm Unique ID: 9708816 Medline TA: Depress Anxiety Country: United States |
Other Details:
|
Languages: eng Pagination: 1008-19 Citation Subset: IM |
Copyright Information:
|
© 2011 Wiley Periodicals, Inc. |
Affiliation:
|
Department of Pediatrics, Brown Center for the Study of Children at Risk, Women and Infants Hospital of Rhode Island and the Department of Pediatrics, Warren Alpert Medical School of Brown University, Providence, Rhode Island 02905, USA. Amy_Salisbury@brown.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Depressive Disorder, Major / complications*, drug therapy Female Gestational Age Humans Infant Behavior / drug effects*, psychology Infant, Newborn Infant, Newborn, Diseases / chemically induced* Neuropsychological Tests Pregnancy Prenatal Exposure Delayed Effects / psychology* Prospective Studies Serotonin Uptake Inhibitors / adverse effects* Severity of Illness Index Young Adult |
| Grant Support | |
ID/Acronym/Agency:
|
K23 MH065479-01/MH/NIMH NIH HHS; K23MH065443/MH/NIMH NIH HHS; K23MH066402/MH/NIMH NIH HHS; K23MH65479/MH/NIMH NIH HHS; R01 MH078033/MH/NIMH NIH HHS; R01 MH078033-01A2/MH/NIMH NIH HHS; R01 MH078033-05/MH/NIMH NIH HHS; R01MH60335/MH/NIMH NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Serotonin Uptake Inhibitors |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sooner or later: age at onset of generalized anxiety disorder in older adults.
Next Document: Treatment-resistant depression in adolescents: review and updates on clinical management.